Prospectively validated model detects infiltrating glioblastoma in targeted biopsies, indicating improved detection strategies.
Motivation: Glioblastoma (GBM) infiltration models lack histopathological validation. Goal(s): GBM infiltration models should be validated with histopathological data of the surrounding peritumoral zone (PZ), which is typically omitted from surgery and difficult to obtain retrospectively. Approach: We prospectively obtained histopathology data from either targeted biopsies (n = 5) or extended peritumoral resection (n = 18). GBM cases with ground truth PZ sampling were used to evaluate the performance of a self-supervised MR fingerprinting (MRF) and multiparametric MRI classifier. Results: Our histopathology-validated infiltration model achieved 70.9% sensitivity and 74.5% specificity in detecting infiltrating glioma, with a mean balanced accuracy of 72.7%. Impact: Glioblastoma (GBM) peritumoral infiltration leads to inevitable recurrence and death. We develop and histopathologically-validate an MRF artificial intelligence (AI) model for pre-surgical prediction of infiltrating GBM to reduce tumor recurrence, improve patient quality of life, and extend survival.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: